GILDER GAGNON HOWE & CO LLC - VIRACTA THERAPEUTICS INC ownership

VIRACTA THERAPEUTICS INC's ticker is VIRX and the CUSIP is 92765F108. A total of 49 filers reported holding VIRACTA THERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is 3.17 and the average weighting 0.0%.

Quarter-by-quarter ownership
GILDER GAGNON HOWE & CO LLC ownership history of VIRACTA THERAPEUTICS INC
ValueSharesWeighting
Q1 2023$255,219
+8.2%
160,515
-0.6%
0.00%0.0%
Q4 2022$235,800
-65.8%
161,507
-0.1%
0.00%
-66.7%
Q3 2022$690,000
+9.4%
161,607
-0.6%
0.01%
+9.1%
Q2 2022$631,000
-27.3%
162,547
-10.9%
0.01%
+37.5%
Q1 2022$868,000
+10.9%
182,396
-15.0%
0.01%
+100.0%
Q4 2021$783,000
-35.5%
214,566
+41.8%
0.00%
-33.3%
Q3 2021$1,214,000
-29.0%
151,350
+0.3%
0.01%
-25.0%
Q2 2021$1,711,000150,8740.01%
Other shareholders
VIRACTA THERAPEUTICS INC shareholders Q1 2023
NameSharesValueWeighting ↓
Aisling Capital Management LP 288,571$1,120,0000.80%
Samsara BioCapital, LLC 689,709$2,676,0000.71%
BVF INC/IL 3,614,662$14,025,0000.68%
HAMILTON LANE ADVISORS LLC 71,491$277,0000.11%
MAI Capital Management 647,950$2,514,0000.05%
Laurion Capital Management LP 698,000$2,708,0000.04%
Jasper Ridge Partners, L.P. 92,939$361,0000.02%
BOURGEON CAPITAL MANAGEMENT LLC 20,500$80,0000.02%
Ergoteles LLC 155,562$604,0000.02%
Clear Harbor Asset Management, LLC 25,000$97,0000.01%
View complete list of VIRACTA THERAPEUTICS INC shareholders